| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 24, 58-73, Copyright © 1978 by American Association for Clinical Chemistry
HU Bergmeyer, P Scheibe and AW Wahlefeld
Conditions for accurate measurement of catalytic activity of aspartate aminotransferase and alanine aminotransferase in human serum have been reinvestigated. The basic variables (kind of buffer, buffer concentration, pH, ion effects, and the influence of pyridoxal-5- phosphate) can now be considered optimized. On this basis, the kinetic parameters of both aminotransferases were determined, i.e., Michaelis and inhibitor constants for substrates and reaction products. With a mathematical approach for two-substrate enzyme reactions the substrate concentrations were calculated from the viewpoints "most economical," "most convenient," and "lowest variability." Also the conditions for the indicator reactions have been newly defined with respect to a kinetic model. All calculated data were rechecked experimentally and it can be shown that both approaches fully agree. Furthermore, we show that the mathematical approach allows more precise recommendations for optimized methods. For technical reasons, the catalytic activity of aspartate aminotransferase in human serum can only be measured as a 0.96 fraction of its theoretical maximum velocity, the catalytic activity of alanine aminotransferase as a 0.91 fraction. The assay conditions for a Reference Method are finally described and recommendations are made for optimized routine methods for determination of the catalytic activity of these transferases in human serum.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  I. Lopez-Aliaga, M. J. M. Alferez, M. T. Nestares, P. B. Ros, M. Barrionuevo, and M. S. Campos Goat Milk Feeding Causes an Increase in Biliary Secretion of Cholesterol and a Decrease in Plasma Cholesterol Levels in Rats J Dairy Sci, March 1, 2005; 88(3): 1024 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Martin and P.-G. Forkert Evidence That 1,1-Dichloroethylene Induces Apoptotic Cell Death in Murine Liver J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Surendran, K. M. Matalon, S. Szucs, S. K. Tyring, and R. Matalon Metabolic Changes in the Knockout Mouse for Canavan's Disease: Implications for Patients With Canavan's Disease J Child Neurol, September 1, 2003; 18(9): 611 - 615. [Abstract] [PDF]
|
|
|
|
|
|
E. J. Martin, W. J. Racz, and P.-G. Forkert Mitochondrial Dysfunction Is an Early Manifestation of 1,1-Dichloroethylene-Induced Hepatotoxicity in Mice J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 121 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Massaguer, S. Perez-del-Pulgar, P. Engel, J. Serratosa, J. Bosch, and P. Pizcueta Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin J. Leukoc. Biol., August 1, 2002; 72(2): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Gluck, R. G. Thomas, K. L. Davis, and V. Haroutunian Implications for Altered Glutamate and GABA Metabolism in the Dorsolateral Prefrontal Cortex of Aged Schizophrenic Patients Am J Psychiatry, July 1, 2002; 159(7): 1165 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jean, S. Rome, V. Mathé, J.-F. Huneau, N. Aattouri, G. Fromentin, C. L. Achagiotis, and D. Tomé Metabolic Evidence for Adaptation to a High Protein Diet in Rats J. Nutr., January 1, 2001; 131(1): 91 - 98. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests Clin. Chem., December 1, 2000; 46(12): 2027 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hensley, Y. Kotake, H. Sang, Q. N. Pye, G. L. Wallis, L. M. Kolker, T. Tabatabaie, C. A. Stewart, Y. Konishi, D. Nakae, et al. Dietary choline restriction causes complex I dysfunction and increased H2O2 generation in liver mitochondria Carcinogenesis, May 1, 2000; 21(5): 983 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kretschmar, B. Hube, T. Bertsch, D. Sanglard, R. Merker, M. Schroder, H. Hof, and T. Nichterlein Germ Tubes and Proteinase Activity Contribute to Virulence of Candida albicans in Murine Peritonitis Infect. Immun., December 1, 1999; 67(12): 6637 - 6642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Stadnicki, J. Chao, I. Stadnicka, E. Van Tol, K.-F. Lin, F. Li, R. B. Sartor, and R. W. Colman Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G854 - G861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Salminen Jr., R. Voellmy, and S. M. Roberts Effect of N-Acetylcysteine on Heat Shock Protein Induction by Acetaminophen in Mouse Liver J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 519 - 524. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Stadnicki, R. B. Sartor, R. Janardham, A. Majluf-Cruz, C. A. Kettner, A. A. Adam, and R. W. Colman Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats FASEB J, March 1, 1998; 12(3): 325 - 333. [Abstract] [Full Text]
|
|
|
|
|
|
F. M. Ndikum-Moffor, T. R. Schoeb, and S. M. Roberts Liver Toxicity from Norcocaine Nitroxide, an N-Oxidative Metabolite of Cocaine J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 413 - 419. [Abstract] [Full Text]
|
|
|
|
|
|
K. P. Navder, E. Baraona, and C. S. Lieber Polyenylphosphatidylcholine Attenuates Alcohol-Induced Fatty Liver and Hyperlipemia in Rats J. Nutr., September 1, 1997; 127(9): 1800 - 1806. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Urgert, S. Meyboom, M. Kuilman, H. Rexwinkel, M. N Vissers, M. Klerk, and M. B Katan Comparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial BMJ, November 30, 1996; 313(7069): 1362 - 1366. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
